› › Fuse Diagnostics

Fuse was established in 2022 by the founders of Sense Biodetection Ltd. Under their leadership Sense raised c.$80m in investment and delivered the world’s first rapid instrument-free, molecular diagnostic test (Veros COVID-19). Sense was subsequently acquired by Sherlock Biosciences Inc.

Recognising that the first generation of molecular instrument-free product platforms do not meet the broader market requirements for point-of-need testing and that molecular technologies are only part of the puzzle, Fuse is leveraging its founders’ extensive experience and knowledge to develop a truly revolutionary new generation of multianalytic diagnostic products.

Product Literature
View Product

Flip mycoplasma

add sample, incubate and flip

Detect mycoplasma contamination in cell culture with unrivalled speed, accuracy and simplicity.

Flip Mycoplasma
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

ACCURATE – Sensitivity of 25 CFU/mL targeting 16S ribosomal RNA for robust specificity.

ULTRA RAPID  – Laboratory PCR performance with a sample to result time of just 12 minutes and a hands-on time of <1 minute.

SIMPLE – Ready-to-use assay format with ambient storage, direct sample detection and a clear visual read out.

FLEXIBLE – Uses any 0.2mL heat block or PCR machine at 50°C, or the USB-C powered Flip Nest.

VERSATILE – Perform rapid molecular quality testing in any location without complex equipment or procedures.

VERIFIED PERFORMANCE – Read the Flip Mycoplasma analytical performance summary here.

Flip Mycoplasma

Product Literature

Quick Use Guide
Analytical Performance Summary
Flip Mycoplasma General Flyer